Cai-Guo Yu
Overview
Explore the profile of Cai-Guo Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cheng Y, Thijs L, Zhang Z, Kikuya M, Yang W, Melgarejo J, et al.
Hypertension
. 2019 Aug;
74(4):776-783.
PMID: 31378104
The new American College of Cardiology/American Heart Association guideline reclassified office blood pressure and proposed thresholds for ambulatory blood pressure (ABP). We derived outcome-driven ABP thresholds corresponding with the new...
12.
Wei F, Thijs L, Yu C, Melgarejo J, Zhang Z, Maestre G, et al.
Hypertension
. 2019 Jul;
74(3):606-613.
PMID: 31280648
Arterial stiffness and wave reflection predict cardiovascular mortality and morbidity and are associated with renal microvascular disease. We hypothesized that the retinal microvascular traits might be associated with central hemodynamic...
13.
Yu C, Wei F, Yang W, Zhang Z, Mujaj B, Thijs L, et al.
Blood Press
. 2019 May;
28(5):279-290.
PMID: 31075995
Aortic pulse wave velocity (aPWV) predicts cardiovascular complications, but the association of central arterial properties with blood lead level (BL) is poorly documented. We therefore assessed their association with BL...
14.
Wei F, Thijs L, Cauwenberghs N, Yang W, Zhang Z, Yu C, et al.
J Am Heart Assoc
. 2019 Apr;
8(7):e011960.
PMID: 31025895
Background Stiffening and calcification of the large arteries are forerunners of cardiovascular complications. MGP (Matrix Gla protein), which requires vitamin K-dependent activation, is a potent locally acting inhibitor of arterial...
15.
Yu C, Wei F, Yang W, Zhang Z, Mujaj B, Thijs L, et al.
Occup Environ Med
. 2019 Apr;
76(6):382-388.
PMID: 30928907
Objectives: Previous studies relating nervous activity to blood lead (BL) levels have limited relevance, because over time environmental and occupational exposure substantially dropped. We investigated the association of heart rate...
16.
Zhao D, Cao Y, Yu C, Yuan S, Zhang N, Zhang Y, et al.
J Clin Hypertens (Greenwich)
. 2019 Mar;
21(5):638-647.
PMID: 30900372
Type 2 diabetes mellitus (T2DM) patients are often accompanied with hypertension. However, the association of antihypertensive drugs with β-cell function has not been well studied. To investigate this question, the...
17.
Yu C, Yang W, Saenen N, Wei F, Zhang Z, Mujaj B, et al.
Scand J Work Environ Health
. 2019 Jan;
45(3):298-307.
PMID: 30631878
Objectives Higher than contemporary exposure levels and advanced age of study participants have limited the interpretation of previous studies relating neurocognitive function to lead exposure. We reassessed this association in...
18.
Yu C, Yuan S, Yang L, Ke J, Zhang L, Lang J, et al.
Am J Ophthalmol
. 2018 Apr;
191:34-41.
PMID: 29621508
Purpose: To investigate whether angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) are differentially associated with the severity of retinopathy in patients with type 2 diabetes mellitus (T2DM). Design: Cross-sectional study....
19.
Yu C, Fu Y, Fang Y, Zhang N, Sun R, Zhao D, et al.
Curr Med Chem
. 2017 Oct;
26(10):1891-1907.
PMID: 28990512
Background: Type-2 diabetes mellitus accounts for 80-90% of diabetic patients. So far, the treatment of diabetes mainly aims at elevating insulin level and lowering glucose level in the peripheral blood...
20.
Yang L, Yu C, Wang X, Yuan S, Zhang L, Lang J, et al.
J Am Heart Assoc
. 2017 Jun;
6(6).
PMID: 28645936
Background: ANGPTL4 (angiopoietin-like protein 4) is a LPL (lipoprotein lipase) inhibitor and is present in high-density lipoprotein (HDL). However, it is not defined whether ANGPTL4 in HDLs could affect HDL...